2017

Funding round led by Sabre Partners & MEMG CDC, with existing investors Accel, IFC, Qualcomm Ventures and Ventureast co-investing. Bangalore, Tuesday 21 November 2017: Portea Medical, India’s leading consumer healthcare brand, today announced Series C funding of US$26 million led by new investors Sabre Partners and MEMG CDC. Portea’s existing investors Accel, International Finance Corporation

Sabre Partners, through its proprietary fund has made an investment of $ 200,000 in AXSLOGIC Private Limited (“AXS:Logic”). AXS:Logic is a Fintech analytics enterprise software company providing cloud and on premise solutions for financial institutions engaged in consumer and commercial lending headquartered in Singapore, with offices in India and the UAE. Axslogic’s flagship product Winnow

Sabre Partners, through its investment entity has invested Rs. 8.2 cr in Thyrocare Technologies Limited (“Thyrocare”). Thyrocare is one of the few pan India chains operating in an attractive industry. It has consistently provided sustained industry leading margins and has displayed a strong track record of growth over the past few years. Thyrocare has successfully

Sabre Partners, through its investment entity has invested $ I mn in Financial Technology Ventures Capital Fund V (“FTV”). FTV Capital, is raising its fifth fund, FTV V, a $700 million (with a $850 million hard cap) growth equity fund focused on the Enterprise Technology & Services, Financial services & Payments space. Through its previous